Literature DB >> 12958169

A potential role for PTTG/securin in the developing human fetal brain.

K Boelaert1, L A Tannahill, J N Bulmer, S Kachilele, S Y Chan, D Kim, N J L Gittoes, J A Franklyn, M D Kilby, C J McCabe.   

Abstract

Human securin, known also as PTTG, has established oncogenic and cell cycle regulatory functions. PTTG/securin transforms cells in vitro, inhibits sister chromatid separation, and regulates secretion of fibroblast growth factor-2. FGF-2 is a key regulator of CNS development and PTTG/securin expression has been reported in murine fetal brain. We examined the expression and function of securin and FGF-2 in the developing human fetal brain and in a fetal neuronal cell line (NT 2). Securin expression was significantly reduced in first and second trimester fetal cerebral cortex compared with adult cerebral cortex, where immunocytochemistry revealed intense securin staining in neuronal cell bodies. FGF-2 protein was concordantly lower in fetal cortex, whereas pretranslational expression of PTTG binding factor (PBF) was not significantly altered in fetal brain compared with adult. PCNA expression demonstrated that high securin levels in adult cortex were associated with absent cell proliferation. In NT-2 cells, securin stimulated FGF-2 expression, which could be abrogated by a carboxyl-terminal mutation. Low transient expression of securin resulted in a significant proliferative effect, whereas high levels of securin expression inhibited cell turnover. We propose a potential role for human PTTG/securin in modulating cell proliferation and FGF-2 expression during human neurogenesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958169     DOI: 10.1096/fj.02-0948com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  11 in total

Review 1.  The emerging role of pituitary tumor transforming gene in tumorigenesis.

Authors:  Jacob Tfelt-Hansen; Deepthi Kanuparthi; Naibedya Chattopadhyay
Journal:  Clin Med Res       Date:  2006-06

2.  Proto-oncogene PBF/PTTG1IP regulates thyroid cell growth and represses radioiodide treatment.

Authors:  Martin L Read; Greg D Lewy; Jim C W Fong; Neil Sharma; Robert I Seed; Vicki E Smith; Erica Gentilin; Adrian Warfield; Margaret C Eggo; Jeffrey A Knauf; Wendy E Leadbeater; John C Watkinson; Jayne A Franklyn; Kristien Boelaert; Christopher J McCabe
Journal:  Cancer Res       Date:  2011-08-15       Impact factor: 12.701

3.  Pituitary tumor transforming gene binding factor: a new gene in breast cancer.

Authors:  Rachel J Watkins; Martin L Read; Vicki E Smith; Neil Sharma; Gary M Reynolds; Laura Buckley; Craig Doig; Moray J Campbell; Greg Lewy; Margaret C Eggo; Laurence S Loubiere; Jayne A Franklyn; Kristien Boelaert; Christopher J McCabe
Journal:  Cancer Res       Date:  2010-04-20       Impact factor: 12.701

4.  Pituitary tumor transforming gene interacts with Sp1 to modulate G1/S cell phase transition.

Authors:  Y Tong; Y Tan; C Zhou; S Melmed
Journal:  Oncogene       Date:  2007-03-12       Impact factor: 9.867

Review 5.  Recent progress in studies of pituitary tumor pathogenesis.

Authors:  Takeo Minematsu; Shunsuke Miyai; Hanako Kajiya; Masanori Suzuki; Naoko Sanno; Susumu Takekoshi; Akira Teramoto; Robert Y Osamura
Journal:  Endocrine       Date:  2005-10       Impact factor: 3.633

6.  MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma.

Authors:  Xiang-Peng Wang; Xing-Li Deng; Li-Yan Li
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

7.  MicroRNA-520d-5p inhibits human glioma cell proliferation and induces cell cycle arrest by directly targeting PTTG1.

Authors:  Tongle Zhi; Kuan Jiang; Xiupeng Xu; Tianfu Yu; Weining Wu; Er Nie; Xu Zhou; Xin Jin; Junxia Zhang; Yingyi Wang; Ning Liu
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

8.  Generation of a panel of antibodies against proteins encoded on human chromosome 21.

Authors:  Frances K Wiseman; Olivia Sheppard; Jacqueline M Linehan; Sebastian Brandner; Victor L J Tybulewicz; Elizabeth M C Fisher
Journal:  J Negat Results Biomed       Date:  2010-08-20

9.  Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction.

Authors:  S-Y Chan; J A Franklyn; H N Pemberton; J N Bulmer; T J Visser; C J McCabe; M D Kilby
Journal:  J Endocrinol       Date:  2006-06       Impact factor: 4.286

10.  Tumorigenic potential of pituitary tumor transforming gene (PTTG) in vivo investigated using a transgenic mouse model, and effects of cross breeding with p53 (+/-) transgenic mice.

Authors:  Miranda Y Fong; Hanan Farghaly; Sham S Kakar
Journal:  BMC Cancer       Date:  2012-11-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.